STACKLOC
Status timeline
- 12 Dec 2024Application filedNew Application Entered
- 18 Feb 2025Assigned to an examining attorneyAssigned To Examiner
- 25 Feb 2025Office action issuedNon-Final Action Written
- 6 Mar 2025Response to office action filedTeas Response To Office Action Received
- 10 Mar 2025Approved for publicationApproved For Pub - Principal Register
- 1 Apr 2025Published for oppositionPublished For Opposition
- 27 May 2025Notice of allowance issued — statement of use requiredNoa E-Mailed - Sou Required From Applicant
- 20 Aug 2025Statement of use filedTeas Statement Of Use Received
- 23 Mar 2026Statement of use acceptedAllowed Principal Register - Sou Accepted
- 14 Apr 2026Registered on the Principal RegisterRegistered-Principal Register
All 22 USPTO events
| 2026-04-14 | Registered-Principal Register |
| 2026-04-14 | Notice Of Registration Confirmation Emailed |
| 2026-03-23 | Allowed Principal Register - Sou Accepted |
| 2026-03-23 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2026-02-26 | Statement Of Use Processing Complete |
| 2026-02-25 | Case Assigned To Intent To Use Paralegal |
| 2025-08-20 | Teas Statement Of Use Received |
| 2025-08-20 | Use Amendment Filed |
| 2025-05-27 | Noa E-Mailed - Sou Required From Applicant |
| 2025-04-01 | Published For Opposition |
| 2025-04-01 | Official Gazette Publication Confirmation E-Mailed |
| 2025-03-26 | Notification Of Notice Of Publication E-Mailed |
| 2025-03-10 | Approved For Pub - Principal Register |
| 2025-03-06 | Teas Response To Office Action Received |
| 2025-03-06 | Correspondence Received In Law Office |
| 2025-03-06 | Teas/Email Correspondence Entered |
| 2025-02-25 | Non-Final Action Written |
| 2025-02-25 | Non-Final Action E-Mailed |
| 2025-02-25 | Notification Of Non-Final Action E-Mailed |
| 2025-02-18 | Assigned To Examiner |
| 2024-12-12 | New Application Entered |
| 2024-12-12 | New Application Office Supplied Data Entered |
Goods & services
Class 5 Pharmaceuticals & supplements
Pharmaceutical feature in the nature of proprietary nutrient-delivery agents that enhance nutrient absorption and bioavailability, namely, a feature in the nature of nutrient delivery agents in the form of powders that provide controlled release of active ingredients for a wide variety of dietary supplements, nutritional supplements, and pharmaceutical preparations, sold as an integral component of dietary supplements, nutritional supplements, and pharmaceutical preparations for the treatment of cardiovascular, neurological, cognitive, digestive, inflammatory, anxiety, weight management, and metabolic health conditions.
First use anywhere 7 Apr 2025 · First use in commerce 7 Apr 2025
Source & freshness
Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 15 Apr 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.